The risks of bleeding, clots and death were not reduced with heparin-free hemodialysis, according to a study in the journal Nephrology Dialysis Transplantation. Clinical outcomes were evaluated for 12,468 patients, and those with a history of gastrointestinal bleeding, lower hemoglobin and platelet counts, and hemorrhagic stroke were more likely to receive heparin-free hemodialysis.
Heparin-free hemodialysis not safer than HD with heparin
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan